Fig. 7From: P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signalingELISA assays of the IFN-γ, TNF-α and IL-6 levels. Supernatants of OC samples with papillary carcinoma were obtained at the end of treatments. IFN-γ: interferon-gamma; TNF-α: tumor necrosis factor alpha; IL-6: interleukin-6. All data are expressed as the mean ± SD. ANOVA complemented by Tukey test was performedBack to article page